Loading…
Underlying
Underlying Price
$38.90
Type
Put
Strike
25
Expiration
Oct 23, 2026
DTE
-1d
Moneyness
OTM
Intrinsic
$0.00
NVO 25 Put Across Expirations
| Expiration | DTE | Last | Change | Vol | Open Int |
|---|---|---|---|---|---|
| Oct 23, 2026 | -1d | — | — | 0 | 0 |
| Oct 30, 2026 | 6d | — | — | 0 | 0 |
| Nov 20, 2026 | 27d | $0.04 | +100.00% | 1,000 | 1,015 |
| Dec 18, 2026 | 55d | $0.05 | +150.00% | 2 | 2,974 |
| Jan 15, 2027 | 83d | $0.02 | -60.00% | 101 | 1,149 |
| Mar 19, 2027 | 146d | $0.12 | -36.84% | 19 | 3,908 |
| Jun 17, 2027 | 236d | $0.44 | -6.38% | 227 | 1,379 |
| Sep 17, 2027 | 328d | $0.73 | -13.10% | 71 | 110 |
| Dec 17, 2027 | 419d | $1.11 | +1.83% | 6 | 3,602 |
| Jan 21, 2028 | 454d | $0.90 | -15.89% | 1 | 2,350 |
| Jun 16, 2028 | 601d | $1.73 | -7.98% | 1 | 17 |
| Dec 15, 2028 | 783d | $1.90 | -9.52% | 3 | 26 |
| Jan 19, 2029 | 818d | $1.87 | -3.11% | 35 | 1,659 |
NVO Profile
Novo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd, Denmark, with production facilities in nine countries and affiliates or offices in five countries.